VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
CMS: Innovative Drug CMS-D001 Receives Clinical Trial Approval from China's NMPA
CMS: Innovative Drug CMS-D001 Receives Clinical Trial Approval from China's NMPA
May 26, 2026 09:06 CST Updated 10:36
Share:
CMS
Professional Drug Developer
